Globally, Fresenius, actively manages 350,000 patients with end-stage renal disease and provides nearly 52 million dialysis treatments annually in about 50 different countries.
from Fresenius building renal genomic registry to inform precision care for kidney disease
https://ift.tt/3cnL6Rd
https://ift.tt/eA8V8J
No comments:
Post a Comment